Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin

Francisco Manuel Ildefonso Mendonça,Francisco J. Martín-Gutiérrez,J.J. Ríos-Martín,Francisco M. Camacho-Martínez

Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin

2016

Francisco Manuel Ildefonso Mendonça
Francisco J. Martín-Gutiérrez
J.J. Ríos-Martín
Francisco M. Camacho-Martínez

Background: Bullous pemphigoid (BP) is an acquired subepidermal autoimmune blistering disease in which there are humoral and cellular responses against the BP180

Keywords:

Dipeptidyl peptidase-4
Dipeptidyl-Peptidase IV Inhibitors
Linagliptin
Dermatology
Vildagliptin
Pemphigoid
Bullous pemphigoid
Medicine
Diabetes mellitus
blistering disease
drug reaction

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations